The French artificial intelligence startup Sonio will be acquired by South Korean tech giant Samsung in order to improve its state-of-the-art medical diagnostic technologies. In recent years, businesses all over the world have spent extensively on integrating Artificial Intelligence (AI) into their products, as its application has surged in a variety of fields, including the medical field.

Sonio’s acquisition by medical equipment manufacturer Samsung Medison, a subsidiary of multinational semiconductor and smartphone giant Samsung Electronics, would improve maternal care with AI-enhanced ultrasound systems.

“Collaboration with Sonio will bring together best-in-class ultrasound AI technology and reporting capabilities to bring a paradigm shift in the prenatal ultrasound exam,” said Yong Kwan Kim, CEO of Samsung Medison.

For $92 million, Samsung will purchase all of Sonio’s shares. The transaction is pending regulatory approval, notably from France. After the deal, Sonio will continue to have its headquarters in France. “In addition to close collaboration with Samsung Medison, as an independent company, Sonio will continue to advance medical reporting technology and diagnostic software globally, including for underserved areas in healthcare,” Sonio CEO Cecile Brosset said.

Sonio’s AI technology improves ultrasound quality, analysis and accuracy using machine learning. With approval for use in the US, its Sonio Detect tool aids in the analysis of fetal pictures, including those of the brain and heart. Samsung once again maintained its AI offerings with the latest acquisition.

The largest memory chip manufacturer in the world, Samsung Electronics supplies chips for premium AI systems from leading manufacturers like Nvidia. The company is also one of the largest smartphone manufacturers globally and its own Galaxy AI technology powers the most recent models.

Read More : https://thecioconnect.com/